Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors

NCT00722228 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hadassah Medical Organization